Objectives: Quaternary ammonium compounds (QACs) are used extensively as biocides and their misuse may be contributing to the development of bacterial resistance. Although the major intrinsic resistance to QACs of Gram-negative bacteria is mediated by the action of tripartite multidrug transporters of the resistancenodulation -division family, we aimed to test if the promiscuity of the recently characterized major facilitator superfamily multidrug transporter, MdtM, from Escherichia coli enabled it also to function in the efflux of QACs.
Introduction
Quaternary ammonium compounds (QACs) are lipophilic cations that are in extensive use as biocides in the aquaculture, farming and food industries, as hand sanitizers and antiseptics in domestic and clinical environments, as preservatives in the cosmetics industry and as microbial corrosion inhibitors in the oil production industry. 1, 2 The frequent use and misuse of QACs in these settings has resulted in the emergence of resistance to disinfectants in pathogenic and non-pathogenic bacteria 3 -6 and there is increasing concern about the possibility of cross-resistance between these compounds and clinically important antibiotics. 1, 7 Although their mechanism of action is not fully understood, QACs are believed to bind to negative charges on the cell membrane and to exert their bactericidal effects by causing cell lysis. 8, 9 Therefore, bacteria must possess mechanisms to defend against this detergent action; one of these is the active extrusion of QACs out of the cell by multidrug resistance (MDR) efflux systems. In Gram-negative Escherichia coli and Pseudomonas aeruginosa, the major intrinsic resistance to QACs is conferred by the resistance-nodulation-division (RND)-type tripartite AcrAB-TolC and the MexAB-OprM multidrug efflux systems, respectively. 10, 11 In E. coli, the small MDR (SMR) transporter SugE also functions in the transport of QACs, 12 and in the Gram-positive bacterium Staphylococcus aureus the MDR transporters QacA and QacB of the major facilitator superfamily (MFS) play an important role in QAC efflux. 13 Apart from the proteins already recognized to function in the efflux of QACs, the E. coli 'effluxome' contains several other multidrug transporters belonging to the RND, MFS, SMR and multidrug and toxic compound extrusion (MATE) families that could potentially contribute to efflux-mediated resistance to those compounds. 14 In addition to the role of the well-characterized MFS MDR transporter MdfA in efflux of the QAC benzalkonium, 15 an analysis of the resistance phenotypes of a drug-hypersensitive strain of E. coli revealed that six other transporters (the MFS member EmrD, the MATE family transporter YdhE, EmrE from the SMR family and the RND proteins AcrEF, YegMNOB and YhiUV) could efflux the same compound when overexpressed from multicopy plasmid. 14 However, as benzalkonium was the only QAC tested in that study, it is not clear if these transporters can efflux any other QACs and the extent of their contribution, if any, to the intrinsic resistance is unknown.
The analysis of single-component multidrug efflux proteins has shown that a highly conserved acidic residue is essential for binding to the positive charge of QACs 16 -18 and that several aromatic residues located within the transmembrane regions of the proteins are involved in forming interactions both with the positive charge and-in the case of QACs that possess them-with the aromatic rings of the substrate. 19, 20 E. coli MdtM, 21 a 410 residue, 12 transmembrane-spanning drug/H + antiporter of the MFS 22 that is implicated in protecting E. coli from the effects of several antibiotics and a handful of other antimicrobials, 14, 15, 23, 24 possesses the requisite conserved, negatively charged acidic residue (Asp-22) as well as several aromatic residues located within the putative transmembranespanning regions of the protein 21 that could potentially function in the recognition and binding of QACs. This led us to hypothesize that MdtM could efflux QACs from the bacterial cell and thus confer resistance. We therefore investigated the resistance phenotype of E. coli BW25113 cells that overproduced MdtM from a multicopy plasmid to a panel of seven QACs (Figure 1) , consisting of benzalkonium chloride (BAC; which is a mixture of three alkyldimethylbenzylammonium chlorides that differ in the length of their alkyl tails 25 ), cetylpyridinium bromide (CPB), cetrimonium bromide (CMB), tetraethylammonium bromide (TEB), domiphen bromide (DPB), dimethyldioctadecylammonium chloride (DODC) and benzethonium chloride (BEC), which are in common use as biocides in industrial, agricultural and clinical settings. To evaluate the existence of any functional interaction between MdtM and AcrAB-TolC 24 in the efflux of QACs from E. coli cells, the resistance phenotype of a drug-hypersensitive E. coli KAM3 acrAB null strain 26 that overproduced MdtM was also investigated. The affinity of MdtM for each QAC was quantified by exploiting intrinsic tryptophan fluorescence quenching of purified protein upon substrate binding in detergent solution. MdtM-mediated QAC transport was assayed by acridine orange fluorescence dequenching studies that used inverted vesicles produced from E. coli KAM3 cells that overproduced the 
Materials and methods
All growth media, general chemicals and QACs were purchased from SigmaAldrich (Poole, Dorset, UK) unless stated otherwise. The pBAD/Myc-His A expression vector was purchased from Invitrogen (Paisley, UK).
Plasmids and bacterial strains
Construction of the pBAD/Myc-His A expression vector containing the E. coli K-12 mdtM open reading frame has been described before. 21 The fidelity of the plasmid, denoted pMdtM (in which mdtM expression is placed under tight control of the araBAD promoter 27 ), was verified by DNA sequence analysis. Plasmid DNA was transformed into E. coli
28 and KAM3 [DacrAB supE hsdD5 thi (Dlac-proAB)/F ′ (traD36 proAB+ lacIq lac DZM15)] cells for the resistance assays; the latter strain was used also for production of inverted vesicles for transport assays. For overproduction of the transporter for purification, pMdtM was transformed into E. coli LMG194 (KS272 Dara714 leu::Tn10).
Western blot analysis was performed to verify the overproduction and correct targeting of recombinant MdtM to the cytoplasmic membrane. Inner membranes from each of the cell strains investigated were prepared as described previously 21 and solubilized by the addition of 1.5% (w/v) dodecyl-b-D-maltopyranoside (DDM; Melford Laboratories Ltd, Ipswich, UK). Samples were run on a 12% bis-Tris gel before being transferred to nitrocellulose membrane. Overexpressed, hexahistidine-tagged MdtM was detected using HisProbe-HRP and SuperSignal West Pico Chemiluminescent Substrate (Pierce Thermo Scientific, Rockford, IL, USA), according to the manufacturer's instructions.
Resistance assays
To test the contribution of MdtM to the intrinsic resistance to a range of QACs, assays in liquid medium were performed with E. coli BW25113 and KAM3 cells transformed with multicopy pMdtM. BW25113 was chosen for these studies, because MdtM is efficiently overproduced, correctly targeted to the cytoplasmic membrane and functional in this strain. 21 The KAM3 strain was used to determine whether MdtM could confer resistance to QACs in the absence of a functional AcrAB-TolC system. Cells harbouring pBAD/Myc-His A vector that did not contain the mdtM open reading frame (referred to subsequently as pBAD or 'empty' vector) were used as controls. Cultures of E. coli BW25113 or KAM3 harbouring either pMdtM or empty vector were grown at 378C in Luria-Bertani (LB) broth supplemented with 100 mg/L carbenicillin (Carbenicillin Direct, UK) to an optical density at 600 nm (OD 600 ) of 0.3. The cultures were then diluted 200-fold into LB broth supplemented with 100 mg/L carbenicillin, 0.002% (w/v) L-arabinose and varying concentrations of the QAC under test, and incubated at 378C with shaking for 6 h prior to the OD 600 being measured. To account for differences in the rate of growth between cells overproducing MdtM and those harbouring 'empty' pBAD, data for each strain were plotted as the percentage growth relative to control cultures of the same cells grown in the absence of the test compound. With the exception of DODC, all the QACs tested were soluble in liquid medium and did not precipitate out of solution at the concentrations used. In the case of DODC, the compound was made up as a 10 mg/mL stock solution in 10% (v/v) ethanol prior to addition to the medium; in the experiments that used DODC, the final concentration of ethanol in the liquid cultures was 1% (v/v). Control experiments using media containing 1% (v/v) ethanol were performed to test for any effects of the alcohol on bacterial growth rates.
All growth experiments were performed in triplicate and fits of the data obtained by SigmaPlot 10 (Systat Software Inc., San Jose, CA, USA) were used to determine the QAC concentration that inhibited cell growth by 50% (the IC 50 value). 29 Statistical analysis of the IC 50 data was performed using a two-tailed Student's t-test. Differences between IC 50 values for cells that overproduced MdtM compared with those for cells that did not overproduce the transporter were considered significant when P, 0.05.
Protein purification
Overproduction and purification of MdtM has been described in detail before. 21 Briefly, an overnight culture grown from a single colony of freshly transformed E. coli LMG194 was diluted 200-fold into 6×1 L of LB broth supplemented with 100 mg/L carbenicillin. Cultures were shaken at 328C for 2.5 h prior to the induction of mdtM expression by the addition of 0.1% (w/v) L-arabinose. Cells were induced for 90 min before harvesting by centrifugation. All subsequent steps were performed at 48C. Cells were resuspended in 30 mL of buffer (50 mM Tris-HCl, pH 7.5, 100 mM NaCl) containing 1 mM phenylmethanesulfonyl fluoride (PMSF), a protease inhibitor cocktail tablet (Roche Diagnostics, West Sussex, UK) and 5 mM DNase. Cells were broken by passage through a French pressure cell and cell membranes were collected by ultracentrifugation. Collected membranes were solubilized by the addition of DDM to 1.5% (w/v) and the solubilized protein was purified using immobilized metal affinity chromatography. Protein fractions were analysed for purity by Coomassie blue-stained 12% bis-Tris SDS-PAGE; those containing purified MdtM were pooled and subjected to thrombin digestion for removal of the hexahistidine affinity tag. The protein then underwent a final 'polishing' step by passage through a Superdex 200 10/300 GL gel filtration column (GE Healthcare, Buckinghamshire, UK) to remove thrombin and cleaved tag. MdtM protein fractions were collected, quantified by the bicinchoninic acid assay (Pierce Thermo Scientific, USA) and then used immediately for substrate binding studies.
Substrate binding assays
The substrate binding affinity of MdtM for each QAC was measured using intrinsic tryptophan fluorescence quenching of the purified protein in detergent solution. Steady-state fluorescence measurements were recorded in triplicate at 258C using a Fluoromax-4 fluorimeter (Horiba UK Ltd, Middlesex, UK) by exciting into the tryptophans at a wavelength of 295 nm and scanning the fluorescence emission from 310 to 400 nm. The excitation and emission slit widths were set to 2.0 and 2.5 nm, respectively. A 0.22 mM solution of freshly purified MdtM in detergent solution [20 mM HEPES, pH 7.0, 10% glycerol, 0.2 mM tris(2-carboxyethyl) phosphine (TCEP), 100 mM NaCl and 0.075% DDM] was titrated with QAC by the sequential addition of 1.0-3.75 mL aliquots of appropriate stock solution until maximal fluorescence quenching of the emission peak at 332 nm was achieved. Control experiments were performed by titrating QAC into buffer only. For all experiments, the total volume of added QAC did not exceed 2.5% of the initial assay volume. After correction for dilution, the data underwent non-linear regression analysis using the formula
The possibility of quenching effects due to non-specific binding of QAC to the protein surface was investigated using purified, urea-denatured MdtM.
In the case of the four QACs (BAC, CPB, DPB and BEC) containing aromatic moieties that absorbed at the 295 nm excitation wavelength employed, the observed fluorescence intensities were corrected experimentally for inner filter effects using a method based on that described by Grkovic et al. 30 The inner filter effects were compensated for by
MdtM-mediated efflux of QACs 833 JAC titration of the QACs into a 1.0 mM solution of free L-tryptophan (Fluka) that gave an initial fluorescence intensity at 332 nm equivalent to that of the 0.22 mM MdtM solution. The measured fluorescence quenching of the free tryptophan solution upon the sequential addition of aliquots of BAC, CPB, DPB or DODC was assumed to be due exclusively to inner filter effects and these data were used to produce corrected fluorescence quenching values (DF corr ) for MdtM titrated with the same QACs using the following equation:
where DF Mq ¼the measured fluorescence quenching of MdtM at a particular QAC concentration, F Mi ¼the initial fluorescence intensity of MdtM without added QAC, DF W ¼the measured fluorescence quenching of free tryptophan at a particular QAC concentration, and F Wi ¼the initial fluorescence intensity of the free tryptophan solution without added QAC. The corrected data underwent analysis as described above for the calculation of apparent substrate binding dissociation constants.
Transport assays
MdtM-mediated QAC transport was demonstrated by measuring the fluorescence dequenching of the pH-sensitive fluorescent indicator acridine orange as H + ions were antiported by MdtM upon addition of QAC to inverted membrane vesicles derived from E. coli KAM3 cells that harboured the recombinant transporter. Control experiments were performed using inverted vesicles produced from cells that harboured 'empty' pBAD and did not therefore overexpress mdtM.
For production of inverted vesicles, cultures of E. coli KAM3 cells freshly transformed with pBAD or pMdtM were grown aerobically at 308C to an OD 600 of 3.0 in LB medium supplemented with 100 mg/L carbenicillin. These cultures were diluted 100-fold into 1 L of LB containing 100 mg of carbenicillin and grown aerobically at 328C for 2.5 h. The temperature was then shifted to 258C. At OD 600 ¼1.0, L-arabinose was added to a final concentration of 0.1% (w/v) and the cells were grown for a further 1.5 h prior to harvesting. Harvested cells were resuspended in TCDS buffer (10 mM Tris-HCl, pH 7.5, 0.14 M choline chloride, 0.5 mM dithiothreitol, 0.25 M sucrose and 5 mM MgCl 2 ) containing 2 mM PMSF, an EDTA-free protease inhibitor cocktail tablet (Roche Diagnostics, West Sussex, UK) and 5 mM DNase. A single passage of the cells through a pre-chilled French pressure cell at 4000 pounds per square inch (psi) generated inverted membrane vesicles. The inverted vesicles were collected by ultracentrifugation, resuspended in 1 mL of TCDS and stored on ice for immediate use in transport assays.
Transport measurements were performed at 258C using a Fluoromax-4 fluorimeter with an excitation wavelength of 492 nm. Fluorescence emission was recorded at 525 nm. The excitation and emission slit widths were set to 1.5 and 2.5 nm, respectively. Inverted membrane vesicles were added to the reaction buffer (1 mM Tris-HCl, pH 7.0, 5 mM MgSO 4 and 1 mM acridine orange) in a quartz cuvette to a final concentration of 0.5 mg/mL membrane protein in a total volume of 1.5 mL. The mixture was allowed to equilibrate for 200 s prior to the addition of 2 mM Tris-dL-lactate, pH 7.0, to generate a DpH (acid inside) and energize the vesicles. Once a stable proton gradient was established (usually after a further 200 s) and the maximal fluorescence quenching was achieved, recording of the fluorescence signal commenced. MdtMmediated transport was initiated by the addition of the tested QAC to the inverted vesicle mixture to the following final concentrations: BAC, 65 mM; TEB, 60 mM; CMB, 40 mM; CPB, 35 mM; DODC, 30 mM; DPB, 50 mM; and BEC, 30 mM. The fluorescence dequenching upon addition of the QAC (due to alkalinization of the vesicle lumen as the proton gradient drove MdtM-mediated QAC uptake into the vesicle) was monitored for an additional 60 s prior to the addition of 100 mM carbonyl cyanide 3-chlorophenylhydrazone (CCCP) to dissipate the DpH and abolish proton-driven transport.
All QAC stock solutions for use in the transport assays, with the exception of DODC, were made up in water and the volume of each stock added to the reaction mixture did not exceed 0.5% of the total reaction volume. DODC stock solution was made up in 10% (v/v) ethanol. Therefore, as a control for the transport assays that used this QAC, an equivalent volume of 10% (v/v) ethanol alone was added to the reaction mixture.
Results
Cells overproducing MdtM are less susceptible to a broad spectrum of QACs A role for MdtM in the efflux of QACs from E. coli has not previously been reported. Therefore, the ability of the mdtM gene product, when overexpressed from multicopy plasmid, to protect E. coli BW25113 and KAM3 cells from the toxic effects of a panel of seven QACs (Figure 1 ) that are constituents of commonly used biocides in the food and cosmetics industries and in clinical settings was determined using growth inhibition assays in liquid medium. Due to the insolubility of one of the QACs (DODC) in water, ethanol was used to solubilize this particular compound. The final concentration of ethanol in the liquid cultures that contained DODC was 1% (v/v) and control experiments verified that the presence of ethanol at this concentration did not affect the bacterial growth rates (data not shown).
As shown in Figure 2 (a), IC 50 values calculated from the growth inhibition assays performed with E. coli BW25113 cells revealed a greater resistance to QACs in cells that overproduced MdtM compared with control cells that harboured empty vector; the observed mean fold increase in resistance to the panel of QACs ranged from 1.2 (for BAC) to 9 (for CPB). In all cases, statistical analysis of the IC 50 data using a two-tailed Student's t-test confirmed that the measured increase in resistance in cells that overproduced MdtM was significant (P,0.05) compared with control cells that did not overproduce the protein.
As expected, due to the lack of a functional AcrAB-TolC efflux system, KAM3 cells were much more susceptible to the cytotoxic effects of all the QACs studied here (Figure 2b ) and the growth of control KAM3 cells that harboured empty pBAD vector was compromised in the presence of each QAC tested. In contrast, complementation of KAM3 with pMdtM resulted in a phenotype that was much less susceptible to the cytotoxic effects of the QACs. Striking differences in the IC 50 values between KAM3 control cells and those complemented with plasmidic mdtM were observed for cells grown in the presence of CPB (20-fold increase in IC 50 ). In addition, cells that overproduced MdtM showed an 8-fold increase in the IC 50 towards CMB and BAC (Figure 2b ). Although MdtM possesses capacity independent of the AcrAB-TolC system to protect cells from the cytotoxic effects of QACs, the IC 50 values for KAM3 cells that overproduced the transporter are much lower than those calculated for the BW25113 cells that contained functional AcrAB-TolC; this highlights the major role played by the latter transport system in the intrinsic resistance of E. coli to this class of antimicrobial. However, taken together, the above results imply a role for MdtM in the intrinsic resistance of E. coli to QACs.
Western blot analysis of DDM-solubilized cytoplasmic membranes from each of the cell strains provided further evidence Holdsworth and Law that the observed differences in susceptibility were related to the functional expression levels of MdtM; recombinant MdtM was detectable only in those cells that harboured the pMdtM vector and the level of MdtM production in both BW25113 and KAM3 cells was similar (Figure 3 ).
MdtM binds QACs with micromolar affinity
Although the results of the growth inhibition assays implicated MdtM in protecting cells from the noxious effects of QACs, we set out to establish definitively that MdtM does indeed bind and transport these compounds. Of the nine tryptophan residues in the amino acid sequence of MdtM, several are located in the putative transmembrane-spanning helices of the transporter and a previous study 21 showed that binding of chloramphenicol substrate to the transporter quenched the fluorescence of one or more of these residues. Therefore, the binding of QACs to MdtM was assayed by exploiting this intrinsic tryptophan fluorescence quenching. The fluorescence emission spectrum of purified MdtM in DDM detergent solution had maximal emission at a wavelength of 332 nm when the protein was excited with light at 295 nm (Figure 4a ). The sequential addition of QAC substrate to the protein solution resulted in an associated decrease in the fluorescence emission intensity at 332 nm until saturation occurred. There was no accompanying shift in the emission wavelength maximum, indicating that the observed quenching was due entirely to the interaction of each QAC with the substrate binding site of MdtM and not to a change in the environment of the tryptophan(s). Further evidence that the observed quenching was due predominantly to interaction between QAC and the MdtM substrate binding site came from control experiments that used urea-denatured protein; in these experiments, no quenching of the fluorescence signal was observed upon sequential addition of each QAC up to a final concentration of 100 mM (data not shown). An additional control experiment confirmed that the sequential addition of aliquots of 10% (v/v) ethanol (used to solubilize DODC) to the protein solution had no effect on the fluorescence emission (data not shown).
Consistent with our postulation of MdtM as a high-affinity QAC-efflux protein, the apparent binding affinity (K d app ) of MdtM for the QACs ranged from 0.3+0.1 to 11.3+1.4 mM, and the order of affinity for the substrates was DPB.DODC .BAC. CPB .TEB .BEC..CMB (Figure 4b-h ). There was a clear substrate-dependent variability in the magnitude of the dilutioncorrected (and, where appropriate, the inner filter effectcorrected) tryptophan fluorescence quenching, which ranged from 3%-4% in the presence of BEC (Figure 4h ) to 12% in the presence of CPB (Figure 4e ).
The electrochemical proton gradient drives MdtM-mediated transport of QACs
The binding studies provided unambiguous evidence for a functional and structural interaction between MdtM and each QAC tested. However, because evidence of binding does not extrapolate to evidence of subsequent transport, we performed a series of assays using inverted membrane vesicles generated from E. coli KAM3 cells that overproduced MdtM to demonstrate that the protein possesses the capacity to catalyse the transport of QACs across the cytoplasmic membrane.
The assays provided clear evidence that MdtM mediated the proton-driven transport of the QACs tested ( Figure 5) . In all cases, the addition of QAC to energized inverted vesicles generated from cells that overproduced MdtM resulted in dequenching of the initial fluorescence signal originating from the pH-sensitive acridine orange fluorophore encapsulated within the vesicles. This fluorescence dequenching was due to alkalinization of the vesicular lumen as protons were pumped out to drive the concomitant MdtM-mediated uptake of the added QAC. Subsequent addition of the protonophore CCCP to abolish the DpH across the vesicle membrane resulted in a further and instantaneous dequenching of the fluorescence signal, indicating that the initial dequenching observed upon the addition of QAC was due to the MdtM-catalysed H + /QAC antiport reaction and not to disruption of the membrane. This contention was supported by control experiments that used inverted vesicles produced from cells that harboured 'empty' pBAD vector and therefore did not overproduce MdtM. As shown in Figure 5 (right-hand panels), addition of TEB, CMB, CPB, DODC, DPB and BEC to those vesicles did not result in dequenching of the fluorescence signal. When BAC was added to control vesicles, however, a small dequenching was observed. This dequenching was probably due to the activity of chromosomally encoded proton-driven transporters, such as MdfA, that also recognize and transport BAC. In all the control experiments, addition of CCCP to the inverted vesicle mixture caused an immediate dequenching of the fluorescence signal, indicating that the vesicular membranes had maintained integrity during the lifetime of the assay.
Taken together, the results of the transport assays provided robust evidence of the following: (i) the fluorescence dequenching observed upon the addition of QAC to inverted vesicles from cells that overproduced MdtM was due solely to QAC/H + antiport activity of the transporter; and (ii) that at the concentrations used in the transport assays, the QACs did not cause disruption of the vesicle membranes. 
Discussion
The indiscriminate use of QACs as biocides in a variety of industrial and clinical settings has resulted in the emergence of resistance to commonly used and clinically important disinfectants in both pathogenic and non-pathogenic bacteria. 1 Furthermore, there is increasing concern about the effects of subinhibitory concentrations of disinfectants in the emergence of resistance in environmental bacteria. 31 There is, therefore, a need for a better understanding of the mechanisms that underpin intrinsic resistance to QACs in bacteria.
Here, we present the first systematic study to show that a single-component multidrug transporter of the MFS, MdtM, is capable of protecting E. coli cells from the toxic effects of a broad range of QACs when overexpressed from a multicopy plasmid. The overproduction of MdtM imparted improved growth to E. coli in the presence of all the QACs tested; comparison of the IC 50 values revealed that cells overexpressing mdtM were statistically less susceptible to the cytotoxic effects of the QACs compared with control cells that did not overexpress the transporter gene (Figures 2 and 3) . While statistically significant, the observed levels of resistance to QACs due to overexpression of mdtM alone are not likely to be generally clinically relevant, because QACs are used at substantially higher concentrations in practice than those studied here. Nevertheless, our work highlights the capacity of MdtM to function effectively in the efflux of QACs and therefore to contribute to resistance. Furthermore, the current study demonstrates the potential of E. coli to respond to environmental threats via the overexpression of a single transporter gene product. Simple up-regulation of the expression or activity of pre-existing transporters that may primarily function in other physiological roles is therefore sufficient to contribute to resistance. This phenomenon may help to explain the persistence and multiplicity of multidrug transporters encoded by bacterial genomes in the absence of a selective pressure from antimicrobials. 32 For example, even though the wellcharacterized E. coli MFS multidrug efflux protein MdfA can recognize and transport a wide range of drugs, 15 it also functions as a Na + (K + )/H + antiporter with a role in alkali tolerance; the latter likely represents its 'true' physiological role. To date, a role independent of multidrug efflux has not been reported for MdtM.
Although several non-transporter gene products have been shown to confer resistance to the QAC benzethonium in E. coli, 23 the major contribution to resistance of QACs in E. coli is imparted by active transporters of the RND family, such as AcrAB. 10 The tripartite AcrAB-TolC complex can capture toxins from the inner membrane phospholipid bilayer and pump them from the periplasm to the cell's exterior, before they can even reach the cytoplasm. 33 Cytotoxic compounds that escape the attention of AcrAB-TolC and penetrate to the cell cytoplasm clearly present a threat to the cell and they too must be removed. Our results supported a role for MdtM in the efflux of cytotoxins from the cell cytoplasm into the periplasmic space, from where the AcrAB-TolC complex can take over and pump them out to the external medium. 21, 24 When AcrAB-TolC is dysfunctional, as in KAM3 cells, MdtM can still remove QACs from the cytoplasm into the periplasmic space. However, if subsequent transport of these compounds from the periplasm to the extracellular surroundings is not sufficiently rapid, they can leak back into the cell and, once a threshold is surpassed, the single-component MdtM transporter can become overloaded and incapable of maintaining sublethal cytoplasmic concentrations of cytotoxins. Therefore, the mechanism of resistance to QACs in E. coli is probably a dual-stage process that depends, in large part, upon a functional interaction between MdtM and the tripartite AcrAB-TolC system. Functional interaction between single-component transporters and RND efflux systems was observed previously in E. coli.
24
The results of the current work conflict with those of a study by Nishino and Yamaguchi, 14 in which the mdtM (formerly named yjiO) gene product expressed from plasmidic DNA had no apparent effect on the resistance phenotype of E. coli KAM3 exposed to the only QAC tested, BAC. Indeed, of the 19 identified E. coli MFS multidrug transporters investigated in that study, only one, EmrD, appeared to confer measurable resistance to BAC.
14 The study by Nishino and Yamaguchi, however, used expression vectors that were different from the one used in the current work. The possibility exists, therefore, that the promoter and/or copy number of the vector(s) used in the study by Nishino and Yamaguchi may have resulted in levels of functional expression insufficient to unmask the role of MdtM (and, perhaps, other MFS multidrug transporters apart from EmrD) in BAC efflux. Moreover, our experiments also included investigation of the resistance phenotype of E. coli cells that preserved AcrAB-TolC efflux pump activity, the relevance of which when investigating the roles of single-component transporters, such as MdtM, in multidrug efflux has been articulated before. 21, 24 The striking difference in the chemical structures of the QACs transported by MdtM (Figure 1) suggests that it acts promiscuously to confer resistance and reinforces the idea of a licentious transporter with a much broader pattern of substrate recognition than previously realized. The binding affinity of MdtM for each QAC was in the low micromolar range; the binding affinities compare well with a previously published K d value for binding of the antibiotic chloramphenicol to MdtM. 21 The origin of the substrate-dependent variability of the intrinsic tryptophan fluorescence quenching observed from the non-vectorial substrate binding assays performed in detergent solution (Figure 4 ) probably lies in differences between how each QAC interacts with the transporter's substrate binding site. Indeed, the MFS multidrug transporter MdfA, a close E. coli homologue of MdtM (41% sequence identity and 62% similarity), 34 possesses a large and flexible substrate binding pocket that can simultaneously accommodate dissimilar substrates. 35 MdtM probably possesses a similar type of binding pocket in which different substrates interact with different regions within it.
The spectrum of substrates transported by MdtM overlaps with those transported by other MDR proteins 14, 15 and this supports that a high degree of functional redundancy with respect to drug efflux is incorporated into E. coli cells to limit cytoplasmic concentrations of cytotoxins. 24 Considering the specificity overlap of single-component multidrug transporters, and their compensatory backup functions, 21, 24 it is possible that others apart from those already recognized to function in QAC efflux may also contribute to protect bacterial cells from the deleterious effects of one or more QACs.
